SCHEMBL5096446

SCHEMBL5096446

CC(C)(C)CC(=O)Nc1ccc(OCc2ccc(Cl)s2)cc1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
ADORA2A P29274 4/20 0.39
ADORA1 P30542 4/20 0.39
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.35
AAK1 Q2M2I8 1/20 0.35
LMNA P02545 2/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
MMP8 P22894 1/20 0.34
MMP12 P39900 1/20 0.34
MMP13 P45452 1/20 0.34
KCNQ2 O43526 3/20 0.34
KCNQ3 O43525 1/20 0.34
EPHX2 P34913 1/20 0.34
MCHR1 Q99705 1/20 0.34
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14138177 0.81 NPC1 (0.41) HTTSMN1; SMN2L3MBTL1LMNAGAA
SCHEMBL3112428 0.80 FFAR1 (0.44) HDAC1HDAC2ADORA2AADORA1HTT
SCHEMBL30795486 0.80 FFAR1 (0.44) HDAC1HDAC2ADORA2AADORA1HTT
SCHEMBL5087363 0.79 HDAC2 (0.36) HDAC1HDAC2L3MBTL1LMNAALDH1A1
SCHEMBL5087391 0.77 HDAC1 (0.52) HDAC1HDAC2KCNQ2KCNQ3
SCHEMBL12199660 0.76 ALDH1A1 (0.52) HDAC1HDAC2ADORA2AADORA1HTT
SCHEMBL5095871 0.76 MAOB (0.50) HDAC1HDAC2ADORA2AADORA1HTT
SCHEMBL30795826 0.70 FFAR1 (0.46) ADORA2AADORA1HTTSMN1; SMN2L3MBTL1
SCHEMBL2070719 0.70 FFAR1 (0.46) ADORA2AADORA1HTTSMN1; SMN2L3MBTL1
SCHEMBL3101696 0.70 KCNQ2 (0.40) HDAC1HDAC2SMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US claimed
US-8722929-B2 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2014-05-13 US disclosed
US-8722929-B2 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2014-05-13 US disclosed
US-8722929-B2 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2014-05-13 US disclosed
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US disclosed
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS KCNB2, KCNJ2, KCNA2 HDAC1 817/4885HDAC2 361/4885ADORA2A 764/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.